The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurodegenerative diseases 1 . Tau assemblies seem to spread through specific neural networks in each disease 2 , with short filaments having the greatest seeding activity 3 . The abundance of tau inclusions strongly correlates with disease symptoms 4 . Six tau isoforms are expressed in the normal adult human brain-three isoforms with four microtubule-binding repeats each (4R tau) and three isoforms that lack the second repeat (3R tau) 1 . In various diseases, tau filaments can be composed of either 3R or 4R tau, or of both. Tau filaments have distinct cellular and neuroanatomical distributions 5 , with morphological and biochemical differences suggesting that they may be able to adopt disease-specific molecular conformations 6,7 . Such conformers may give rise to different neuropathological phenotypes 8,9 , reminiscent of prion strains 10 . However, the underlying structures are not known. Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau 11 . Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia. The filaments consist of residues Lys254-Phe378 of 3R tau, which are folded differently from the tau filaments in Alzheimer's disease, establishing the existence of conformers of assembled tau. The observed tau fold in the filaments of patients with Pick's disease explains the selective incorporation of 3R tau in Pick bodies, and the differences in phosphorylation relative to the tau filaments of Alzheimer's disease. Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers.
Using helical reconstruction in RELION 22 , we determined a 3.2 Å resolution map of the ordered core of NPFs, in which side-chain densities were well resolved and β-strands were clearly separated along the helical axis ( Fig. 1f and Extended Data Fig. 2 ). We also determined a map of WPFs, which was limited to 8 Å resolution because of the small number of filaments. This was sufficient to show separated β-sheets within the structure, but not the 4.7 Å spacing of individual β-strands along the helical axis ( Fig. 1g and Extended Data Fig. 3 ). NPFs are composed of a single protofilament with an elongated structure that is markedly different from the C-shaped protofilament of paired helical filaments (PHFs) and straight filaments found in Alzheimer's disease 11, 23 . WPFs are formed by the association of two NPF protofilaments at their distal tips. In support, we observed WPFs in which one protofilament had been lost in some parts (Extended Data Fig. 3 ). Our results reveal that the tau filaments of Pick's disease adopt a single fold that is different from that of the tau filaments found in Alzheimer's disease.
The high-resolution NPF map allowed us to build an atomic model of the Pick tau filament fold (hereafter termed the Pick fold), which 1 MRC Laboratory of Molecular Biology, Cambridge, UK. 2 Letter reSeArCH consists of residues Lys254-Phe378 of 3R tau (in the numbering of the 441-amino-acid human tau isoform) ( Fig. 2 ). There are nine β-strands (β1-β9) arranged into four cross-β packing stacks and connected by turns and arcs. R1 provides two strands, β1 and β2, and R3 and R4 provide three strands each, β3-β5 and β6-β8, respectively. These strands pack together in a hairpin-like fashion: β1 against β8, β2 against β7, β3 against β6, and β4 against β5. The final strand, β9, is formed from nine amino acids after R4 and packs against the opposite side of β8. Only the interface between β3 and β6 is entirely hydrophobic; the other cross-β packing interfaces are composed of both non-polar and polar side chains.
The interstrand connections and their interactions maintain the strand pairings and compensate for differences in strand lengths and orientations. A sharp right-angle turn at Gly261, between β1 and β2, faces a smooth four-residue arc formed by 355-Gly-Ser-Leu-Asp-358, between β7 and β8, turning the protein chain in the same direction. The 270-Pro-Gly-Gly-Gly-273 motif between β2 and β3 gives rise to an omega-shaped turn that compacts the protein chain locally, but maintains its direction at either end. On the opposite side, a β-arc formed of Glu342 and Lys343, between β6 and β7, creates space for this turn. By contrast, the homologous 332-Pro-Gly-Gly-Gly-335 motif connecting β5 and β6 forms an extended β-spiral conformation, compensating for the shorter lengths of these strands compared to the opposing β3 and β4, which are connected by Pro312. Solvent-mediated interactions may occur within the large cavity between this motif and the side chains at the junction of β3 and β4. The third homologous 364-Pro-Gly-Gly-Gly-367 motif contributes to a 180° turn that allows β9 to pack against the other side of β8. Variations in the height of the chain along the helical axis also help to maintain an ordered hydrogen-bonding pattern of the β-stranded regions (Fig. 3c) .
The solvent-exposed side chains of Cys322 and Ser324, together with the intervening Gly323, form a flat surface at the hairpin turn between β4 and β5. This provides the interface for the formation of WPFs by the abutting of protofilaments (Extended Data Fig. 3 ). The distances between protofilaments at this interface would enable van der Waals interactions, but not the formation of disulfide bonds. In support, WPFs were stable under reducing conditions (Extended Data Fig. 3 ). At the resolution of the WPF map, it was not possible to determine whether protofilament β-strands are aligned or staggered by one half of the β-strand distance, as is the case for PHFs in Alzheimer's disease 11 . We conclude that WPFs are formed by two separate protofilaments making tight contacts at their distal tips through van der Waals interactions.
Three regions of less well-resolved density bordering the solventexposed faces of β4, β5 and β9 are apparent in the unsharpened maps of both NPFs and WPFs ( Fig. 1f, g) . Their low resolution suggests that they represent less ordered, heterogeneous and/or transiently occupied structures. The density bordering β4 is similarly located, but more extended and less-well resolved, than that found to interact with the side chains of Lys317, Thr319 and Lys321 in Alzheimer's disease PHFs and straight filaments 11 , and hypothesized to be the N-terminal 7-Glu-Phe-Glu-9, part of the discontinuous MC1 epitope 24 . NPFs and WPFs were labelled by MC1 (Extended Data Fig. 1 ).
It was not previously known why only 3R tau, which lacks the second microtubule-binding repeat, is present in Pick body filaments. Our results suggest that despite sequence homology, the structure formed by Lys254-Lys274 of the first tau repeat is inaccessible to the corresponding residues from the second repeat of 4R tau (Ser285-Ser305). The site occupied by Thr263, which is in close proximity to the backbone of the opposite strand β7, cannot accommodate the bulkier side chain of Lys294 from 4R tau and does not provide a favourable environment for its charged ε-amino group (Extended Data Fig. 4 ). Also, the site preceding the omega-like structure formed by 270-Pro-Gly-Gly-Gly-273 cannot accommodate a C β branched residue, such as Val300 from 4R tau instead of Gln269 from 3R tau. In addition, the smaller Cys291 residue from 4R tau would form weaker interactions with Leu357 and Ile360 than those formed by Ile260 of 3R tau. In support, tau filaments extracted from the brain of the patient with Pick's disease used for cryo-EM seeded the aggregation of recombinant fulllength 3R, but not 4R, tau (Extended Data Fig. 5 ). Similar experiments have shown that Alzheimer's disease PHFs and straight filaments, the core sequences of which are shared by 3R and 4R tau, can seed both types of isoform 25 . Such templated misfolding explains the selective incorporation of 3R tau in Pick body filaments. Pick's disease extracts have been reported to seed the aggregation of a 4R tau fragment comprising the repeats (residues 244-372) with mutations Phe301Leu and Val337Met 26 . However, this tau fragment cannot form the Pick fold, which is unable to accommodate R2 and requires residues 373-378. A small amount of aggregated four-repeat tau may have accounted for the seeding activity, as suggested in a separate study 8 . Loss of von Economo neurons in anterior cingulate and frontoinsular cortices has been reported to be an early event in Pick's disease 27, 28 . It remains to be established how 3R tau seeds can form in cells that also express 4R tau. Alternatively, nerve cell populations may be distinguished by the tau isoforms that they express 29 .
The cryo-EM structures presented here were derived from filaments that were extracted from the brain of a single patient with Pick's disease (patient 4). To test the generality of the Pick fold, we investigated the binding of repeat-specific antibodies to tau filaments extracted from the frontotemporal cortex of eight additional patients with sporadic Pick's disease (Extended Data Table 1 ). By western blotting, all samples ran as two tau bands of 60 and 64 kDa, which were detected by anti-R1, anti-R3 and anti-R4 antibodies, but not by an anti-R2 antibody, showing the presence of only 3R tau (Extended Data Fig. 6 ). Immunogold negative-stain electron microscopy showed that most filaments were NPFs, with a minority of WPFs, and were not decorated by the repeat-specific antibodies (Extended Data Fig. 7 ). This shows that the R1, R3 and R4 epitopes are inaccessible to the antibodies used, indicating that they form part of the ordered filament core. Alzheimer's disease PHFs and straight filaments are decorated by anti-R2, but not by anti-R3 or anti-R4 antibodies, because their core is made of R3, R4 and the 10 amino acids following R4 11, 30 . These results are in good agreement with experiments using limited proteolysis and mass spectrometry 7 . We conclude that the ordered core of tau filaments from Pick's disease comprises the C-terminal part of R1, all of R3 and R4, as well as 10 amino acids after R4.
Unlike PHFs and straight filaments in Alzheimer's disease, Pick body filaments are not phosphorylated at Ser262 and/or Ser356 14, 16 (Extended Data Fig. 1 ). The reasons for this differential phosphorylation are unknown. Our structure reveals that the tight turn at Gly261 prevents phosphorylation of Ser262 in the ordered core of Pick's disease filaments, whereas the phosphorylated Ser262 is outside the ordered core of Alzheimer's disease filaments 11 . This explains the differential phosphorylation and raises the question of whether phosphorylation at Ser262 may protect against Pick's disease.
In the Pick and Alzheimer tau filament folds, most β-structure residues between Val306 and Ile354 align locally, as do the connecting segments of Pro312, 332-Pro-Gly-Gly-Gly-335 and 342-Glu-Lys-343 ( Fig. 3 ). Almost all amino acid side chains from this region have the same interior or solvent-exposed orientations in both folds. Exceptions are Cys322 and Asp348, which cause reversed chain directions in one or other fold (Fig. 3d ). The side chain of Cys322 is interior in the Alzheimer tau filament fold, whereas it is solvent-exposed in the Pick fold. This enables the hairpin-like turn and the cross-β packing of β4 against β5. The side chain of Asp348 is interior in the Pick tau filament fold, thereby maintaining the β-structure from Lys343 to Ile354 (β7), whereas it is solvent-exposed in the Alzheimer fold, enabling the tight turn between β5 and β6, which, together with β4, gives rise to a triangular β-helix conformation 11 . Such β-helices, previously thought to be important for propagation 31 , are absent from the Pick tau filament fold. The β-strands in Gly355-Phe378 align well in both folds, but have different cross-β packing arrangements. The solvent-exposed side chains of β7 and β8 in the Alzheimer fold are interior in the equivalent strands of the Pick fold (β8 and β9), because of different conformations of the two turn regions in R4, 355-Gly-Ser-Leu-Asp-358 and 364-Pro-Gly-Gly-Gly-367. The 355-Gly-Ser-Leu-Asp-358 motif makes a sharp right-angle turn at Gly355 in the Alzheimer tau filament fold, but a wide turn in the Pick fold. The same sharp turn is found at the homologous site in R1 in the Pick tau filament fold, whereas the same wide turn occurs at the homologous site in R3 in the Alzheimer fold ( Fig. 3 ). This suggests that these semi-conserved turn structures may also be found in tau filament folds in other diseases. By contrast, the 364-Pro-Gly-Gly-Gly-367 motif adopts a new conformation in the Pick fold, which reverses the chain direction and is different from both the right-angle turn that this motif forms in the Alzheimer fold and the conformations of the homologous Pro-Gly-Gly-Gly motifs from the other repeats in both tau filament folds. The Pick and Alzheimer folds share similar secondary structure patterns, but different turn conformations result in distinct cross-β packing.
These findings show that the ordered cores of tau filaments from Pick's disease adopt a single, novel fold of 3R tau, which is distinct from Letter reSeArCH the tau filament fold found in Alzheimer's disease. This suggests that additional folds may be found in tauopathies with 4R tau filaments, such as progressive supranuclear palsy. Our results also suggest that single, disease-specific folds may exist in tauopathies with the same tau filament isoform composition, such as progressive supranuclear palsy and corticobasal degeneration, since identical tau sequences can adopt more than one fold. Conserved secondary structure motifs and markedly different conformations at turn residues in the Alzheimer and Pick tau filament folds may form the basis for structural diversity in tau protein folds from other neurodegenerative diseases. The structures of different tau filament folds will provide the basis for determining the binding sites of tau ligands and give a rationale for their interactions with inclusions in different tauopathies 32 .
The identification of disease-specific folds in the ordered cores of tau filaments establishes the existence of molecular conformers. This is central to the hypothesis that conformers of filamentous tau give rise to the clinical phenotypes that define distinct tauopathies, akin to prion strains. By revealing the structural basis for molecular conformers in specific diseases, our results pave the way to a better understanding of a wide range of diseases related to abnormal protein aggregation.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment. Extraction of tau filaments. Sarkosyl-insoluble material was extracted from the grey matter of frontal and temporal cortex of the patients' brains, as described 33 . Approximately 6 g tissue was used for cryo-EM and 0.6 g tissue was used for immunolabelling. The pelleted sarkosyl-insoluble material was resuspended in 50 mM Tris-HCl pH 7.4 containing 150 mM NaCl and 0.02% amphipol A8-35 at 250 µl per g tissue, followed by centrifugation at 3,000g for 30 min at 4 °C. The pellets, containing large contaminants, were discarded. The supernatants were centrifuged at 100,000g for 30 min at 4 °C. The resulting pellets were resuspended in buffer at 15 µl per gram tissue for cryo-EM and 150 µl per g tissue for immunolabelling. Pronase treatment was carried out as described for negative-stain EM 33 and cryo-EM 11 . Tau filaments were incubated with 0.4 mg ml −1 pronase (Sigma) for 5 min at 21 °C before being deposited on EM grids and plunge-frozen. Recombinant tau. Tau constructs lacking the BR136, anti-4R, BR135 and TauC4 peptide sequences were cloned from pRK172 encoding wild-type 0N4R or 2N4R tau using the QuikChange Lightning site-directed mutagenesis kit (Agilent), according to the manufacturer's instructions. All recombinant tau proteins were expressed and purified as described 34 . Immunolabelling and histology. Western blotting and immunogold negativestain EM were carried out as described previously 33 . For western blotting, samples were resolved on 4-20% or 10% Tris-glycine gels (Novex), and the primary antibodies were diluted in PBS plus 0.1% Tween 20 and 1% bovine serum albumin (BSA). BR136 is a polyclonal antibody that was raised against a synthetic peptide corresponding to residues 244-257 of tau. The peptide (200 µg), coupled to keyhole limpet haemocyanin using glutaraldehyde, was mixed 1:1 with Freund's complete adjuvant and used to immunize white Dutch rabbits. Booster injections using 200 µg of conjugated peptide mixed 1:1 with Freund's incomplete adjuvant were given every 2 weeks for 10 weeks after the primary immunization. Antibodies were obtained 7 days after the final booster injection and affinity purified. Extended Data Fig. 6 shows that BR136 is specific for the C-terminal region of residues 244-257. Neurohistology and immunohistochemistry were carried out as described previously 35 . Brain sections were 8-µm thick and were counterstained with haematoxylin. Detailed antibody information is provided in Extended Data Table 2 . Whole-exome sequencing. Whole-exome sequencing was carried out at the Center for Medical Genomics of Indiana University School of Medicine using genomic DNA from the nine individuals with neuropathologically confirmed diagnoses of Pick's disease, the tau filaments of which were used in Extended Data Figs. 6 and 7. Target enrichment was performed using the SureSelectXT human all exon library (V6, 58Mb, Agilent) and high-throughput sequencing using a HiSeq4000 (2 × 75-bp paired-end configuration, Illumina). Bioinformatics analyses were performed as described 36 . Findings on MAPT, PSEN1 and APOE are presented in Extended Data Table 1 . Seeded aggregation. Seeded aggregation was carried out as described 37 , but with full-length wild-type tau protein and without the aggregation inducer heparin. Recombinant 0N3R and 0N4R tau were purified as described 34 . Extracted tau filaments (15 µl per g tissue) were diluted 1:10 in 10 mM HEPES pH7.4, 200 mM NaCl; 2 µl was added to 98 µl of 20 µM 0N3R or 0N4R recombinant tau in the same buffer with 10 µM thioflavin T in a black, clear bottom 96-well plate (Perkin Elmer). The plate was sealed and incubated at 37 °C in a plate reader (BMG Labtech FLUOstar Omega), with cycles of shaking for 60 s (500 r.p.m., orbital) followed by no shaking for 60 s. Filament formation was monitored by measuring thioflavin T fluorescence every 45 min using 450 ± 10 nm excitation and 480 ± 10 nm emission wavelengths, with an instrument gain of 1,100. Three independent experiments were performed with separate recombinant protein preparations. Electron cryo-microscopy. Extracted, pronase-treated tau filaments (3 µl at a concentration of approximately 0.5 mg ml −1 ) were applied to glow-discharged holey carbon grids (Quantifoil Au R1.2/1.3, 300 mesh) and plunge-frozen in liquid ethane using an FEI Vitrobot Mark IV. Images were acquired on a Gatan K2-Summit detector in counting mode using an FEI Titan Krios at 300 kV. A GIF-quantum energy filter (Gatan) was used with a slit width of 20 eV to remove inelastically scattered electrons. In total, 52 movie frames were recorded, each with an exposure time of 250 ms using a dose rate of 1.06 electrons per Å 2 per frame, for a total accumulated dose of 55 electrons per Å 2 at a pixel size of 1.15 Å on the specimen. Defocus values ranged from −1.7 to −2.8 µm. Further details are presented in Extended Data Table 3 . Helical reconstruction. Movie frames were corrected for gain reference, motion-corrected and dose-weighted using MOTIONCOR2 38 . Aligned, nondose-weighted micrographs were used to estimate the contrast transfer function (CTF) in Gctf 39 . All subsequent image-processing steps were performed using helical reconstruction methods in RELION 2.1 22, 40 . NPFs and WPFs were picked manually and processed as separate datasets. NPF dataset. NPF segments were extracted using a box size of 270 pixels and an inter-box distance of 14 Å. Reference-free 2D classification was performed using a regularization value of T = 2, and segments contributing to suboptimal 2D class averages were discarded. An initial helical twist of −0.73° was estimated from the crossover distances of NPFs in micrographs, and the helical rise was estimated to be 4.7 Å. Using these values, an initial 3D reference was reconstructed de novo from 2D class averages of segments comprising an entire helical crossover. A first round of 3D classification, starting from the de novo initial model low-pass filtered to 40 Å, with local optimization of the helical twist and rise, and a regularization value of T = 4 yielded a reconstruction in which individual β-sheets perpendicular to the helical axis were clearly separated, but no structure was discernable along the helical axis. Subsequently, 3D auto-refinement with optimization of helical twist and rise and a regularization value of T = 10 was performed using the segments that contributed to the 3D class displaying β-sheets. The resulting reconstruction showed clearly discernible β-strand separation.
An additional round of 3D classification with a regularization value of T = 10 starting from the 5 Å low-pass filtered map from the previous auto-refinement was used to select further segments for a final high-resolution refinement. In total, 16,097 segments contributed to the final map. The reconstruction obtained with this relatively small subset of the initial dataset matched lower-resolution reconstructions obtained with larger subsets of the data, indicating that image classification did not select for a specific structure from a conformationally heterogeneous dataset, but instead was successful in distinguishing the segments with high-resolution information from images of varying quality. This is in line with observations in single-particle analysis 41 . Superimposing the selected segments onto the original micrographs further confirmed this. Image classification also did not separate filaments with variable twists; instead, RELION combines segments from filaments with variable twists into a single 3D reconstruction and reduces the corresponding blurring effects by only using the central part of an intermediate asymmetrical reconstruction for real-space helical symmetrisation 22 . We used a 10% value for the corresponding helical z_percentage parameter Optimization of the helical twist and rise converged onto −0.75° and 4.78 Å, respectively. Refinements with helical rises of multiples of 4.78 Å all led to β-strand separation, but in agreement with the observed absence of layer lines between 50 and 4.7 Å we were unable to detect any repeating patterns along the helical axis other than the successive rungs of β-strands.
The final NPF reconstruction was sharpened using standard post-processing procedures in RELION, resulting in a B-factor of −57 Å 2 (Extended Data Table 3 ). Helical symmetry was imposed on the post-processed map using RELION helix toolbox 22 . Final, overall resolution estimates were calculated from Fourier shell correlations at 0.143 between the two independently refined half-maps, using phase-randomization to correct for convolution effects of a generous, soft-edged solvent mask 42 . The overall resolution estimate of the final map was 3.2 Å. Local resolution estimates were obtained using the same phase-randomization procedure, but with a soft spherical mask that was moved over the entire map. WPF dataset. The WPF dataset was down-scaled to a pixel size of 3.45 Å and segments were extracted using a box size of 180 pixels and an inter-box distance of 14 Å. As with the NPF dataset, an initial 3D reference was reconstructed de novo from 2D class averages of segments comprising an entire helical crossover. 3D classification was then performed to discard suboptimal segments. 3D auto-refinement of the best class with a regularization value of T = 4 and a fixed helical rise and twist of 4.7 Å and −0.6°, respectively, led to a 3D structure with good separation of β-sheets perpendicular to the helical axis, but no structure was discernible along the helical axis. The cross-section of this map clearly revealed the presence of two NPF protofilaments. To further improve the reconstruction, we also made an initial model by placing two NPF maps, rotated 180° relative to each other in the WPF reconstruction, and low-pass filtering the resulting map to 60 Å. After a second 3D auto-refinement starting from this model, the final WPF reconstruction had an estimated overall resolution of 8 Å and was sharpened by specifying a B-factor of −200 Å 2 (Extended Data Table 3 ). In total, 3,003 segments contributed to the final map. Model building and refinement. A single monomer of the NPF core was built de novo in the 3.2 Å resolution reconstruction using COOT 43 . Model building was started from the distinctive extended β-spiral conformation of the 332-Pro-Gly-Gly-Gly-335 motif, neighbouring the large histidine side chains of residues 329 and 330, and working towards the N-and C-terminal regions by manually adding amino acids, followed by targeted real-space refinement. This assignment of amino acids was unambiguous due to the clear densities of the three Pro-Gly-Gly-Gly motifs and the large aromatic side chains of Tyr310 and Phe346. The model was then translated to give a stack of three consecutive monomers to preserve nearest-neighbour interactions for the middle chain in subsequent refinements using a combination of real-space refinement in PHENIX 44 and Fourier-space Letter reSeArCH refinement in REFMAC 45 . In the latter, local symmetry restraints were imposed to keep all β-strand rungs identical. Because most of the structure adopts a β-strand conformation, hydrogen bond restraints were imposed to preserve a parallel, in-register hydrogen bonding pattern in earlier stages of the model building process. Side-chain clashes were detected using MOLPROBITY 46 and corrected by iterative cycles of real-space refinement in COOT and Fourier-space refinement in REFMAC. The refined model of the NPF was rigid-body fitted into the WPF map. Separate NPF model refinements were performed against a single half-map, and the resulting model was compared to the other half-map to confirm the absence of overfitting. The final model was stable in refinements without additional restraints. Ethical review board and informed consent. The Indiana Alzheimer Disease Center studies were reviewed and approved by the Indiana University Institutional Review Board. Informed consent was obtained from the patients' next of kin. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. Cryo-EM maps have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-0077 for NPF and EMD-0078 for WPF. The NPF refined atomic model has been deposited in the Protein Data Bank (PDB) under accession number 6GX5. Whole-exome sequencing data that support the findings of this study have been deposited in the European Genome-Phenome Archive (EGA), which is hosted by the EBI and the CRG, under accession number EGAS00001003106.
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Extended Data Fig. 4 | Incompatibility of the Pick tau filament fold with 4R tau. Atomic model of the Pick fold with the 4R tau sequence overlaid. The region formed by Lys254-Lys274 from R1 is replaced by the Ser285-Val300 region from R2 in 4R tau. Residues that differ between these regions of R1 and R2 are coloured orange. The major discrepancies of lysine at position 294 in R2, instead of threonine at position 263 in R1, and valine at position 300 in R2, instead of glutamine at position 269 in R1, are highlighted with dashed red outlines. The minor discrepancy of weaker interactions of Cys291 of R2 with Leu357 and Ile360 compared with those formed by Ile260 of R1 is highlighted with a dashed yellow outline.
Extended data table 1 | Summary of the patients with Pick's disease
Wild-type (wt) means that no known disease-causing mutations in the tau gene (MAPT) or the presenilin-1 gene (PSEN1) were detected. The patient used for cryo-EM is highlighted in yellow.
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